HNRNPA2B1 and central nervous system cancer: Similarly, the downregulated expression of FTO enhances the m6A modification of primary microRNA-10a (pri-miR-10a), which can be recognized by the reader HNRNPA2/B1 and increase the glioma tumour burden (142).